2020
DOI: 10.1016/j.medmal.2020.01.001
|View full text |Cite
|
Sign up to set email alerts
|

Comparative review of imipenem/cilastatin versus meropenem

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(14 citation statements)
references
References 60 publications
0
14
0
Order By: Relevance
“…Cefepime and meropenem were the most effective agents, which were 100% effective against both Gram-positive and Gram-negative bacteria in our study. They are all used as firstline antimicrobials in human hospitals [46,47]. However, cefepime has proven to have adverse effects on the gastrointestinal tract of horses [48]; thus, the further evaluation of the pharmacokinetics of cefepime in donkeys prior to clinical administration is necessary.…”
Section: Discussionmentioning
confidence: 99%
“…Cefepime and meropenem were the most effective agents, which were 100% effective against both Gram-positive and Gram-negative bacteria in our study. They are all used as firstline antimicrobials in human hospitals [46,47]. However, cefepime has proven to have adverse effects on the gastrointestinal tract of horses [48]; thus, the further evaluation of the pharmacokinetics of cefepime in donkeys prior to clinical administration is necessary.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the negative results of the CSF bacteriological tests, severe clinical condition and staphylococcal bacteraemia, statistically associated with a 10% -30% risk of ME coexistence, necessitated the use of dual pharmacotherapy in this patient using both antiviral drugs and broad-spectrum antibiotics [16]. The treatment used was VAN -an antistaphylococcal glycopeptide antibiotic, MP -an antibiotic from the group of carbapenems, and CTX -characterized by excellent penetration through the inflamed blood-brain barrier [17,18,19]. Molecular virological diagnostics did not show the presence of genetic material of CMV and SARS-CoV-2 coronavirus in CSF.…”
Section: Discussionmentioning
confidence: 99%
“…To our knowledge, this was the first study to compare the carbapenems prescription pattern between the COVID-19 ICU and the GICU. Meropenem was the preferred agent used, as it had better activities on gram-negative bacteria and central nervous system penetration [ 30 ]. This is consistent with the observations in the recent systematic reviews [ 3 , 5 ].…”
Section: Discussionmentioning
confidence: 99%